Baolin Du, Wei Li, Jingwen Sun, Yeteng Zhang, Jun Hong
{"title":"Predictive Tool for Early Neurological Deterioration in Acute Minor Vertebrobasilar Occlusive Stroke Managed Medically.","authors":"Baolin Du, Wei Li, Jingwen Sun, Yeteng Zhang, Jun Hong","doi":"10.1016/j.wneu.2025.124304","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>We sought to construct a scoring model to predict early neurological worsening (END) among minor vertebrobasilar occlusive strokes (National Institutes of Health Stroke Scale [NIHSS] score < 6) following best medical management (BMM).</p><p><strong>Methods: </strong>Between January 2019 and June 2024, 137 patients were recruited from a single center. END was characterized by a ≥ 4-point rise in NIHSS within 72 hours, without intracranial hemorrhage. Logistic regression analysis identified predictors for END, which were used to construct a scale. External validation was performed using a separate cohort from another hospital during the same study period (n=81). Model performance was assessed using receiver operating characteristic (ROC) curve analysis, area under the curve (AUC), calibration plots, and Brier score.</p><p><strong>Results: </strong>END occurred in 41 patients (29.9%). Independent predictors for END were fluctuating symptoms (adjusted odds ratio [aOR] = 1.64, assigned 1 point), proximal vertebrobasilar occlusion (aOR = 2.59, assigned 2 points), and Tmax > 6 seconds volumes (aOR = 1.87, assigned 1 point) (all P < 0.001). The predictive scale showed excellent discrimination in the derivation cohort (AUC = 0.921, 95% confidence interval [CI]: 0.882-0.965) and good calibration (Brier score = 0.103). The derivation and validation cohorts were similar in most baseline characteristics. Significant differences were observed in symptom evolution, intravenous thrombolysis usage, and occlusion sites. External validation in an independent cohort yielded an AUC of 0.857 (0.825-0.934) and a Brier score of 0.130.</p><p><strong>Conclusions: </strong>This externally validated scale provided a practical tool to identify high-risk END patients for targeted interventions.</p>","PeriodicalId":23906,"journal":{"name":"World neurosurgery","volume":" ","pages":"124304"},"PeriodicalIF":2.1000,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World neurosurgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.wneu.2025.124304","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: We sought to construct a scoring model to predict early neurological worsening (END) among minor vertebrobasilar occlusive strokes (National Institutes of Health Stroke Scale [NIHSS] score < 6) following best medical management (BMM).
Methods: Between January 2019 and June 2024, 137 patients were recruited from a single center. END was characterized by a ≥ 4-point rise in NIHSS within 72 hours, without intracranial hemorrhage. Logistic regression analysis identified predictors for END, which were used to construct a scale. External validation was performed using a separate cohort from another hospital during the same study period (n=81). Model performance was assessed using receiver operating characteristic (ROC) curve analysis, area under the curve (AUC), calibration plots, and Brier score.
Results: END occurred in 41 patients (29.9%). Independent predictors for END were fluctuating symptoms (adjusted odds ratio [aOR] = 1.64, assigned 1 point), proximal vertebrobasilar occlusion (aOR = 2.59, assigned 2 points), and Tmax > 6 seconds volumes (aOR = 1.87, assigned 1 point) (all P < 0.001). The predictive scale showed excellent discrimination in the derivation cohort (AUC = 0.921, 95% confidence interval [CI]: 0.882-0.965) and good calibration (Brier score = 0.103). The derivation and validation cohorts were similar in most baseline characteristics. Significant differences were observed in symptom evolution, intravenous thrombolysis usage, and occlusion sites. External validation in an independent cohort yielded an AUC of 0.857 (0.825-0.934) and a Brier score of 0.130.
Conclusions: This externally validated scale provided a practical tool to identify high-risk END patients for targeted interventions.
期刊介绍:
World Neurosurgery has an open access mirror journal World Neurosurgery: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review.
The journal''s mission is to:
-To provide a first-class international forum and a 2-way conduit for dialogue that is relevant to neurosurgeons and providers who care for neurosurgery patients. The categories of the exchanged information include clinical and basic science, as well as global information that provide social, political, educational, economic, cultural or societal insights and knowledge that are of significance and relevance to worldwide neurosurgery patient care.
-To act as a primary intellectual catalyst for the stimulation of creativity, the creation of new knowledge, and the enhancement of quality neurosurgical care worldwide.
-To provide a forum for communication that enriches the lives of all neurosurgeons and their colleagues; and, in so doing, enriches the lives of their patients.
Topics to be addressed in World Neurosurgery include: EDUCATION, ECONOMICS, RESEARCH, POLITICS, HISTORY, CULTURE, CLINICAL SCIENCE, LABORATORY SCIENCE, TECHNOLOGY, OPERATIVE TECHNIQUES, CLINICAL IMAGES, VIDEOS